Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review
Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Nahid Abbas, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 5, pp. 1347-1355
Open Access | Times Cited: 20

Showing 20 citing articles:

Antinutrients: Lectins, goitrogens, phytates and oxalates, friends or foe?
Martha L. López-Moreno, M. Garcés-Rimón, M.Carmen Miguel
Journal of Functional Foods (2022) Vol. 89, pp. 104938-104938
Open Access | Times Cited: 86
Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques
Chrysi Keskinidou, Alice G. Vassiliou, Ioanna Dimopoulou, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 3501-3546
Open Access | Times Cited: 30
Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID‐19 outcomes: Genome‐wide cross trait analysis and bidirectional Mendelian randomization study
Minhao Yao, Xin Huang, Yunshan Guo, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 22
Acteoside inhibits high glucose-induced oxidative stress injury in RPE cells and the outer retina through the Keap1/Nrf2/ARE pathway
Jingfei Yang, Zhijuan Hua, Zhikun Zheng, et al.
Experimental Eye Research (2023) Vol. 232, pp. 109496-109496
Open Access | Times Cited: 18
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 10
Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection
Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 23-49
Open Access | Times Cited: 15
Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti‐SARS‐CoV‐2 Activity
Bianca Schulte, Maria König, Beate I. Escher, et al.
ChemMedChem (2022) Vol. 17, Iss. 5
Open Access | Times Cited: 14
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 8
Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19
Rebekah Penrice-Randal, Xiaofeng Dong, Andrew Shapanis, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Transcription factor Nrf2 as a potential therapeutic target for COVID-19
Yifan Wang, Jing Ma, Yongfang Jiang
Cell Stress and Chaperones (2022) Vol. 28, Iss. 1, pp. 11-20
Open Access | Times Cited: 10
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
Yuanyuan Qiao, Jesse W. Wotring, Yang Zheng, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 30
Open Access | Times Cited: 4
Composition decipherment of Ficus pumila var. awkeotsang and its potential on COVID-19 symptom amelioration and in silico prediction of SARS-CoV-2 interference.
Hao-Chun Hu, Szu-Yin Yu, Xiao-Shan Hung, et al.
Journal of Food and Drug Analysis (2022) Vol. 30, Iss. 3, pp. 440-453
Open Access | Times Cited: 7
The Relationship between Nrf2 and HO-1 with the Severity of COVID-19 Disease
Damir Mihić, Domagoj Loinjak, Lana Maričić, et al.
Medicina (2022) Vol. 58, Iss. 11, pp. 1658-1658
Open Access | Times Cited: 6
Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the NFE2L2/KEAP1 Polymorphisms in Regulating SARS-CoV-2 Infection
Marí­a Elena Soto, Giovanny Fuentevilla-Álvarez, Adrián Palacios Chavarría, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 415-415
Open Access | Times Cited: 3
In-silico analysis of SARS-CoV-2 N protein host interactors involved in Parkinson’s Disease and Dementia
Priyanjal Jain, Urshila Naithani, Vijeta Prakash, et al.
Research Square (Research Square) (2024)
Open Access
Association of using enteral nutrition containing probiotics and dietary inflammatory index with inflammatory factors serum levels and gastrointestinal complications in infected patients with COVID-19
Mahsa Mohajeri, Negin Abedi
Nutrition & Food Science (2024) Vol. 54, Iss. 7, pp. 1219-1233
Closed Access
Nitazoxanide Activating Keap1a/Nrf2 Signaling Pathway is Regulated by Cul3 of Criataria Plicata
Chungen Wen, Wuting Lu, Feixiang Su, et al.
(2024)
Closed Access
Alterations in plasma proteome during acute COVID-19 and recovery
Maciej Suski, Agnieszka Olszanecka, Aneta Stachowicz, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
Nebulized Ethanol: An Old Treatment for a New Disease
Steven W. Stogner
IntechOpen eBooks (2023)
Open Access | Times Cited: 1
Could Targeting miRNA-142-5p Be a Therapeutic Strategy Against COVID-19 Through Activation of The Anti-Inflammatory Nrf2/Keap1 Pathway?
Engy Medhat, Mai Samir, Riem M. Elmessiery, et al.
Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology/Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology (2022) Vol. 14, Iss. 1, pp. 175-186
Open Access | Times Cited: 1
Page 1

Scroll to top